Analyst Price Targets — CROX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 2:49 pm | Brooke Roach | Goldman Sachs | $81.00 | $95.29 | TheFly | Crocs price target raised to $81 from $71 at Goldman Sachs |
| February 13, 2026 2:10 pm | Jonathan Komp | Robert W. Baird | $110.00 | $94.48 | TheFly | Crocs price target raised to $110 from $100 at Baird |
| February 13, 2026 12:22 pm | — | Stifel Nicolaus | $99.00 | $98.46 | TheFly | Crocs price target raised to $99 from $90 at Stifel |
| February 13, 2026 11:14 am | — | Barclays | $109.00 | $98.46 | TheFly | Crocs price target raised to $109 from $86 at Barclays |
| February 12, 2026 7:14 pm | — | Piper Sandler | $95.00 | $98.46 | TheFly | Crocs price target raised to $95 from $85 at Piper Sandler |
| February 12, 2026 4:04 pm | — | Needham | $118.00 | $100.15 | TheFly | Crocs price target raised to $118 from $100 at Needham |
| January 7, 2026 10:45 am | Jonathan Komp | Robert W. Baird | $100.00 | $89.08 | TheFly | Crocs downgraded to Neutral from Outperform at Baird |
| December 5, 2025 2:07 pm | Jay Sole | UBS | $85.00 | $89.99 | StreetInsider | UBS Reiterates Neutral Rating on Crocs (CROX) as 'Fundamentals Have Deteriorated YTD' |
| October 31, 2025 12:00 pm | Peter McGoldrick | Stifel Nicolaus | $90.00 | $81.01 | StreetInsider | Crocs (CROX) PT Raised to $90 at Stifel |
| October 31, 2025 9:32 am | — | Barclays | $86.00 | $82.54 | TheFly | Crocs price target raised to $86 from $81 at Barclays |
Latest News for CROX
111 Capital bought a new stake in shares of Crocs, Inc. (NASDAQ: CROX) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 6,087 shares of the textile maker's stock, valued at approximately $509,000. A number of other large
A Crocs executive recently sold 12,145 shares directly for a transaction value of ~$1.22 million on Feb. 20, 2026. This sale represented 8.48% of the executive's direct holdings prior to the transaction.
Himalaya Capital Management bought 628,159 shares of Crocs in the fourth quarter. The quarter-end position value increased by $53.72 million as a result of the new holding.
CROX joins three other low-PEG stocks screening for growth, liquidity and value metrics to help investors sidestep potential traps.
Consumer confidence rebounds as inflation fears ease, spotlighting RSI, CROX, CALY, DLB and MCFT on upbeat earnings revisions.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for CROX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.